News
Post Doctoral Scientist post available at Boehringer - Research Beyond Borders working with the UK Cystic Fibrosis Gene Therapy Consortium
2 months ago The UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
2 months ago Flutterby Fundraisers to Sponsor Consortium Scientist
11 months ago New Publication - Gelinas et al 2017 - Media Supplements to Improve Lentiviral Vector Production Yields
1 year ago Gene Therapy Funding Update
1 year ago Consortium Student Live Facebook Interview from ASGCT
1 year ago
2 months ago The UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
2 months ago Flutterby Fundraisers to Sponsor Consortium Scientist
11 months ago New Publication - Gelinas et al 2017 - Media Supplements to Improve Lentiviral Vector Production Yields
1 year ago Gene Therapy Funding Update
1 year ago Consortium Student Live Facebook Interview from ASGCT
1 year ago
Latest News
Consortium Featured in Observer Magazine
The work of the Consortium was featured in an Observer Magazine article by Robin McKie.
9 years ago
VGXi Sign Deal to Manufacture DNA for the Consortium
VGXi Pharmaceuticals sign a multi-year production agreement with the United Kingdom Cystic Fibrosis Gene Therapy Consortium.
10 years ago
Ian Pringle Wins Outstanding Young Scientist Award at BSGT
Consortium Scientist Dr Ian Pringle won the Lez Fairbairn award for the Outstanding Young Scientist at the BSGT Conference in London
12 years ago
Laboratory Automation (2007): Our Biomek NX is used to purify RNA/DNA from samples and also to setup a range of assays in the lab. The precision of the 'robot' is greater than human pipetting and allows us to massively increase the throughput of sample processing. More...
